Trials / Completed
CompletedNCT01068028
Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741
Safety, Tolerability and Pharmacokinetics of Multiple Escalating Doses of ORM-12741
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple ascending doses of ORM-12741.
Detailed description
The purpose is to evaluate the safety, tolerability and pharmacokinetics of escalating multiple doses of ORM-12741 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ORM-12741 | Ascending multiple doses to sequential panels |
| DRUG | Placebo for ORM-12741 |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-06-01
- Completion
- 2010-07-01
- First posted
- 2010-02-12
- Last updated
- 2010-08-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01068028. Inclusion in this directory is not an endorsement.